Zhu et al. [28] confirmed that the METTL3/YTHDF1 axis, mediating m6A methylation, regulated the proliferation and cisplatin sensitivity of BC cells through targeting the PI3K/AKT pathway. Here, AKT1 is linked to breast cancer.